New bladder cancer drug TARA-002 faces off against chemo in major trial
Disease control
Not yet recruiting
This study tests a new drug called TARA-002 for people with a type of bladder cancer that hasn't spread into the muscle. About 284 adults will get either TARA-002 or standard chemotherapy. The goal is to see if TARA-002 works better at making the cancer disappear and is safe.
Phase: PHASE3 • Sponsor: Protara Therapeutics • Aim: Disease control
Last updated May 14, 2026 12:06 UTC